Yim D - Search Results

1

SU-E-J-172: Development of a Video Guided Real-Time Patient Motion Monitoring System for Helical Tomotherpay.

Ju S, Hong C, Yim D, Kim M, Kim J, Han Y, Shin J, Shin E, Ahn S, Choi D. Ju S, et al. Among authors: yim d. Med Phys. 2012 Jun;39(6Part8):3692. doi: 10.1118/1.4735011. Med Phys. 2012. PMID: 28518927

2

SU-E-T-292: New Technique for Developing Proton Range Compensator Using Three-Dimensional Printer.

Ju S, Kim M, Hong C, Yim D, Kim J, Shin D, Lee S, Han Y, Shin J, Shin E, Ahn S, Choi D. Ju S, et al. Among authors: yim d. Med Phys. 2012 Jun;39(6Part14):3770-3771. doi: 10.1118/1.4735360. Med Phys. 2012. PMID: 28517248

3

Population pharmacokinetics of arbekacin in burn patients.

Kim JH, Lah HO, Yim DS. Kim JH, et al. Eur J Clin Pharmacol. 2008 Jun;64(6):599-603. doi: 10.1007/s00228-008-0470-1. Eur J Clin Pharmacol. 2008. PMID: 18320181

4

A population pharmacokinetic-pharmacodynamic model for simvastatin that predicts low-density lipoprotein-cholesterol reduction in patients with primary hyperlipidaemia.

Kim J, Ahn BJ, Chae HS, Han S, Doh K, Choi J, Jun YK, Lee YW, Yim DS. Kim J, et al. Basic Clin Pharmacol Toxicol. 2011 Sep;109(3):156-63. doi: 10.1111/j.1742-7843.2011.00700.x. Epub 2011 May 14. Basic Clin Pharmacol Toxicol. 2011. PMID: 21426490 Free article.

5

A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomas.

Kim SJ, Kang HJ, Kim JS, Eom HS, Huh J, Ko YH, Lee J, Yim DS, Lee SY, Park WS, Yang WI, Lee SS, Suh C, Kim WS. Kim SJ, et al. Invest New Drugs. 2013 Dec;31(6):1514-21. doi: 10.1007/s10637-013-0015-z. Epub 2013 Aug 24. Invest New Drugs. 2013. PMID: 23975510 Clinical Trial.

6

What Does it Take to Make Model-Informed Precision Dosing Common Practice? Report from the 1st Asian Symposium on Precision Dosing.

Polasek TM, Rostami-Hodjegan A, Yim DS, Jamei M, Lee H, Kimko H, Kim JK, Nguyen PTT, Darwich AS, Shin JG. Polasek TM, et al. AAPS J. 2019 Jan 9;21(2):17. doi: 10.1208/s12248-018-0286-6. AAPS J. 2019. PMID: 30627939

7

Population pharmacokinetics of meropenem in burn patients.

Doh K, Woo H, Hur J, Yim H, Kim J, Chae H, Han S, Yim DS. Doh K, et al. J Antimicrob Chemother. 2010 Nov;65(11):2428-35. doi: 10.1093/jac/dkq317. Epub 2010 Sep 3. J Antimicrob Chemother. 2010. PMID: 20817742

8

Population pharmacokinetic analysis of fluconazole to predict therapeutic outcome in burn patients with Candida infection.

Han S, Kim J, Yim H, Hur J, Song W, Lee J, Jeon S, Hong T, Woo H, Yim DS. Han S, et al. Antimicrob Agents Chemother. 2013 Feb;57(2):1006-11. doi: 10.1128/AAC.01372-12. Epub 2012 Dec 17. Antimicrob Agents Chemother. 2013. PMID: 23254425 Free PMC article.

9

Combined effect of GSTM1, GSTT1, and COMT genotypes in individual breast cancer risk.

Park SK, Yim DS, Yoon KS, Choi IM, Choi JY, Yoo KY, Noh DY, Choe KJ, Ahn SH, Hirvonen A, Kang D. Park SK, et al. Among authors: yim ds. Breast Cancer Res Treat. 2004 Nov;88(1):55-62. doi: 10.1007/s10549-004-0745-x. Breast Cancer Res Treat. 2004. PMID: 15538046

10

SAFETY OF A CRM197-CONJUGATED HAEMOPHILUS INFLUENZAE TYPE B VACCINE IN KOREAN CHILDREN.

Song H, Bock H, Guadagno A, Costantini M, Baehner F, Kim YH, Ahn SI, Son KH, Yim DS. Song H, et al. Southeast Asian J Trop Med Public Health. 2015 Jul;46(4):743-52. Southeast Asian J Trop Med Public Health. 2015. PMID: 26867395

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

436 results

Search Page

Filters